
- Telehealth Visits
- Insurance plan information


Nasim Sobhani, MD
Obstetrics- Telehealth Visits
- Insurance plan information




Nasim Sobhani, MD
Obstetrics- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Nasim Sobhani is a perinatologist, an obstetrician who specializes in high-risk pregnancy care. Her expertise encompasses comprehensive management of patients with preexisting conditions that can affect pregnancy and of those with pregnancy-specific conditions. She serves as medical director of the UCSF Endocrine, Diabetes and Pregnancy Program, which oversees the care of pregnant patients with preexisting or gestational diabetes. She also cares for developing fetuses diagnosed in utero with genetic or structural conditions. She sees patients in both the hospital and the clinic.
Because diabetes is the most common medical complication of pregnancy, Sobhani's research centers on optimizing care for pregnant people living with diabetes. To that end, she studies how to diagnose and manage gestational diabetes, how to improve outcomes before and after birth for pregnant patients with type 1 or 2 diabetes, and how to leverage new diabetes technologies in the treatment of pregnant people.
Sobhani earned her medical degree from the University of Texas Southwestern Medical School. She completed a residency in obstetrics and gynecology at the University of Washington, followed by a fellowship in maternal-fetal medicine at UCSF.
Education & training
Board certification
- Maternal-Fetal Medicine, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Maternal and Fetal Medicine, UCSF Graduate Medical Education
Residency
- Obstetrics & Gynecology, University of Washington School of Medicine
Degree
- MD, University of Texas Southwestern Medical School
My expertise
Specialties
- Obstetrics
Conditions
Locations
My research
Clinical trials
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesOpens in a new window
Recruiting
LGA will be defined as a birthweight ≥90th%tile for gestational age based on a US birth certificate reference adjusted for parity and/or fetal sex. Neonatal…Commercial or Open Source Closed Loop Impact on Pregnancy StudyOpens in a new window
Recruiting
Primary neonatal outcome. LGA defined as birth weight > 90th percentile for gestational ageAutomated Insulin for Management of Intrapartum GlycemiaOpens in a new window
Recruiting
A primary clinical goal of intrapartum glycemic management is to minimize the likelihood of low neonatal glucose values (hypoglycemia).
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.